Book a free demo with us
Book Now

Yemaachi Biotechnology

Yemaachi Biotechnology uses cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies for lowering the economic burden of cancer.

Total Fundraised$5B

PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
Calendar Image2020
Established
HeadquarterGradient ImageAccra, Ghana
Headquarter
OperationalGradient Image
GHA
Operational Market
SectorGradient Image
Biotech
Biotechnology
Bioinformatics
Artificial Intelligence
Artificial Intelligence (AI)
Primary Sector
EmployeeGradient Image11 - 49
Employees
PinGradient ImageSeed
Current Stage
GlobeGradient Imagehttps://www.yemaachi.com/
Website

Funding Types by Funds Raised (in USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Cumulative Funding Raised Over Time

Content Locked

Login or Register a FREE account to continue browsing our content

Yemaachi Biotechnology's Investors by Funding Rounds

Funding Round

Announced Date

Disclosed Investors

Round Amount (USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Yemaachi Biotechnology's Key
Team Members

Yaw Bediako, Ph.D.
David (Kojo) Hutchful